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Neonatal immune challenge by administration of lipopolysaccharide (LPS) produces
enduring alterations in the development and activity of neuroendocrine, immune and
other physiological systems. We have recently reported that neonatal exposure to an
immune challenge by administration of LPS results in altered reproductive development
in the female Wistar rat. Specifically, LPS-treated animals exhibited diminished ovarian
reserve and altered reproductive lifespan. In the current study, we examined the
cellular mechanisms that lead to the previously documented impaired ovulation and
reduced follicular pool. Rats were administered intraperitoneally either 0.05mg/kg of LPS
(Salmonella Enteritidis) or an equivalent volume of non-pyrogenic saline on postnatal
days (PNDs) 3 and 5, and ovaries were obtained on PND 7. Microarray analysis
revealed a significant upregulation in transcript expression (2-fold change; p < 0.05)
for a substantial number of genes in the ovaries of LPS-treated animals, implicated
in immune cell signaling, inflammatory responses, reproductive system development
and disease. Several canonical pathways involved in immune recognition were affected
by LPS treatment, such as nuclear factor-κB (NF-κB) activation and LPS-stimulated
mitogen-activated protein kinase (MAPK) signaling. Quantitative Real-time PCR analysis
supported the microarray results. Protein expression analysis of several components of the
MAPK signaling pathway revealed a significant upregulation in the expression of Toll-like
receptor 4 (TLR4) in the neonatal ovary of LPS-treated animals. These results indicate
that neonatal immune challenge by administration of LPS has a direct effect on the ovary
during the sensitive period of follicular formation. Given the pivotal role of inflammatory
processes in the regulation of reproductive health, our findings suggest that early life
immune activation via TLR signalingmay have significant implications for the programming
of ovarian development and fertility.
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INTRODUCTION
Worldwide there is a trend for declining fertility. This is par-
ticularly apparent for the female population, whereby 10.9%
of women suffer from impaired fertility and 6% are infertile
(Martinez et al., 2012). Decreased female fecundity has been
related to advanced maternal age but the increasing representa-
tion of young women in this category (Martinez et al., 2012),
suggests a more complex epidemiology. Accumulating evidence
points to the critical role of the early life environment in the
establishment of reproductive health. Substantial epidemiologi-
cal and experimental evidence indicates that adult physiological
function and health status may have their origins in the early
developmental period (Barker and Osmond, 1986; Barker et al.,
1989; Barker, 1990). Plasticity during the perinatal period allows
adequate adaptation of an organism to given environmental con-
ditions and predicts later life functioning. While physiological
plasticity holds a beneficial value for the developing organism,
exposure to adverse environmental conditions during critical
maturational periods, may result in alterations to the normal
developmental trajectory, increasing susceptibility to physiolog-
ical malfunction and pathology in later life. The process by which
early life environment can have permanent effect on physiologi-
cal systems has been described as perinatal programming (Welberg
and Seckl, 2001; Davies and Norman, 2002).
One of the major physiological systems that undergoes devel-
opment and maturation during foetal and early postnatal life
is the immune system. Due to functional immaturity of the
neonatal immune system in both animals and humans, there
is increased susceptibility to infections and a lower response
to immunogenic stimuli when compared to that of the adult
(Vosters et al., 2010). The impaired immune responses, upon
exposure to infectious agents, during the perinatal period have
been associated with the decreased capacity of the neonate to
develop mature protective T helper type 1 immune responses
(De Wit et al., 2003). As such, low levels of proinflammatory
cytokines have been detected in response to immune stimulation
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by LPS and Staphylococcus epidermidis as documented in neona-
tal rats and mice, as well in human cord blood (Angelone et al.,
2006; Hartel et al., 2008; Hodyl et al., 2008). The development
of the immune system is well-established to be dependent on the
immune, autonomic and endocrine signals that it receives early in
life (Holladay and Smialowicz, 2000; Zakharova, 2009; Fagundes
et al., 2012). This physiological programming of the immune sys-
tem and its relationship to later life pathology has been associated
with a number of long-term health outcomesmediated by inflam-
matory pathways including, a predisposition to asthma, allergies,
autoimmune diseases, metabolic disorders, cardiovascular dis-
eases, multiple sclerosis, and more (Zakharova, 2009; Fagundes
et al., 2012), depending on the timing and the extent of early life
immunogenic exposure.
Programming of the immune system has been investigated
using various animal models. Experimentally-induced early life
immune activation is commonly achieved by administration of
lipopolysaccharide (LPS) [derived from Salmonella Enteritidis
or Escherichia (E.) coli], the cell wall of Gram-negative bacte-
ria, in rodents. LPS is recognized by the Toll-like receptor 4
(TLR4) that is expressed by several cell types, such as mono-
cytes, macrophages, adipocytes as well as gonadal supporting cells
(i.e., ovarian granulosa and testicular sertoli cells) (Medzhitov,
2001; Richards et al., 2008). The impact of neonatal LPS exposure
has been examined on a variety of physiological and behavioral
outcomes, such as adult immune responses (Boisse et al., 2004;
Spencer et al., 2006; Walker et al., 2009b; Mouihate et al., 2010),
metabolism (Walker et al., 2006; Iwasa et al., 2009a), brain mor-
phology (Bilbo et al., 2008; Amath et al., 2012; Sominsky et al.,
2012b), stress responsivity, and anxiety-like behaviors (Walker
et al., 2009a, 2012; Sominsky et al., 2013).
The reciprocal relationship between the hypothalamic-
pituitary-gonadal (HPG) axis and the immune system has an
extensive impact on development and functioning of both sys-
tems, as well as on health outcomes. Oestrogen and androgen
receptors are expressed on immune cells (Tanriverdi et al., 2003),
and these in turn have been shown to populate all reproduc-
tive organs (Seamark et al., 1992). Recently, increasing attention
has focused on the effect of neonatal immune challenge on
reproductive development and functioning. Activation of the
immune system during neonatal life has long-term consequences
for reproductive functioning (Marchetti et al., 2000; Morale et al.,
2003). Experimental evidence has indicated altered puberty onset,
diminished HPG axis activity and impaired sexual behavior in
both male and female rodents neonatally exposed to bacterial
endotoxin, LPS, in particular on PNDs 3 and 5 (Iwasa et al.,
2009b,c; Knox et al., 2009; Walker et al., 2011; Wu et al., 2011;
Sominsky et al., 2012a), suggesting that these changes may be
attributed to the critical window of reproductive development.
Supporting this assertion, the critical period for programming
of pubertal onset in the female rat has been determined to be
before 7 days of age. LPS treatment on PNDs 3 and 5 has been
shown to result in a significant delay in puberty, while LPS
administered on PNDs 7 and 9 or PNDs 14 and 16 produced
no such effect (Knox et al., 2009). Furthermore, neonatal LPS
exposure has been demonstrated to aggravate LPS-induced sup-
pression of LH pulse frequency in adulthood, when compared to
neonatal saline-treated group (Li et al., 2007). Similarly, neona-
tal LPS-treated female rats exhibited prolonged oestrous cycle in
response to LPS injection in adulthood, while no such response
was observed in neonatal saline-treated animals (Iwasa et al.,
2009c).
Neonatal LPS exposure has also been reported to pro-
duce alterations in gonadal morphology. Reduced gonocyte
populations in neonatal testes, as well as increased epithelial
disorganization and delayed spermatogenesis in adulthood were
demonstrated in male rats neonatally exposed to LPS (Walker
et al., 2011). Robust alterations in gonadal morphology in
response to neonatal LPS challenge have also been documented in
female animals. Diminished follicular reserve has been detected
in the ovaries of LPS-treated female rats (Wu et al., 2011), with
reduced population of primordial follicles being evident at 2
weeks of age, after LPS exposure on PNDs 3 and 5 (Sominsky
et al., 2012a). This later finding corresponded with advanced
senescence and poor pregnancy outcomes in LPS-treated females
(Sominsky et al., 2012a), suggesting a prolonged and more robust
effect of an immune challenge on female reproductive lifespan.
Of particular relevance to the model of neonatal immune chal-
lenge, is that the initial follicular assembly and maturation are
known to be dependent on local inflammatory agents, such as
growth factors and cytokines (Dissen et al., 2002; Skinner, 2005;
Schindler et al., 2010). Even after puberty, when ovarian func-
tion is largely governed by the HPG hormones (McGee and
Hsueh, 2000), ovulation resembles an inflammatory process, as
constituted by increased vasodilation and hyperaemia of ovarian
follicles, and their ability to produce cytokines, chemokines, and
prostaglandins (Espey, 1980; Richards et al., 2002). This concept
is further strengthened by the abundance of macrophages, princi-
pal innate immune cells, in the ovary, contributing to the regula-
tion of ovarian function (Wu et al., 2004). Furthermore, ovarian
granulosa and cumulus cells exert several immune-related func-
tions, including the expression of TLR4, which during ovulation
respond to endogenous ligands, resulting in the release of pro-
inflammatory cytokines, such as IL-6 (Richards et al., 2008).
While immune-regulation of ovarian function is crucial for
normal fertility, any alteration in this delicate relationship may
lead to ovarian dysfunction and subfertility. Common ovar-
ian diseases, such as polycystic ovarian syndrome (PCOS) and
endometriosis, have been associated with increased levels of fol-
licular and serum pro-inflammatory cytokines, constitutive of
chronic low grade inflammation (Wu et al., 2004). The direct
impact of LPS exposure on ovarian function has been previ-
ously assessed in-vitro, and was reported to result in diminished
follicular function (Herath et al., 2007) and impaired oocyte
meiotic competence (Bromfield and Sheldon, 2011). No stud-
ies have investigated in vivo the mechanisms that underpin the
effect of peripheral LPS exposure on ovarian development dur-
ing the neonatal period. In the current study, we aimed to
identify the ovarian pathways that lead to the previously docu-
mented impaired ovulation and reduced oocyte development, in
the model of dual LPS exposure on PNDs 3 and 5 (Knox et al.,
2009; Wu et al., 2011; Sominsky et al., 2012a). In order to char-
acterize the cellular mechanisms that underpin the immediate
effect of peripheral LPS exposure on PNDs 3 and 5 on ovarian
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development, we examined its effect on the ovarian transcriptome
on PND 7. Given that in the rat, the assembly of primordial fol-
licles is not established until PND 3 (Rajah et al., 1992; Skinner,
2005), we propose that an immune challenge by administration
of LPS at this time point may directly intervene with the forma-
tion and establishment of the finite follicular pool via activation
of inflammatory pathways.
METHODS
ANIMALS AND NEONATAL TREATMENT
All animal experimental procedures were conducted with the
approval of the University of Newcastle Animal Care and Ethics
Committee (ACEC). Seven experimentally naive female Wistar
rats were obtained from the University of Newcastle animal house
and mated in the University of Newcastle Psychology vivarium.
Animals were maintained under normal housing conditions at
21–22◦C, under a 12 h light/dark regime. At birth (PND 1), whole
litters were randomly allocated into either LPS (4 litters; litter size
M = 13, SD = 1.8) or saline-treated conditions (3 litters; litter
size M = 15, SD = 0). As documented previously (Walker et al.,
2004, 2006, 2009a,b, 2010; Sominsky et al., 2012a,b), on PNDs 3
and 5 pups were briefly removed from their home cages, weighed
and administered intraperitoneally with either LPS (Salmonella
enterica, serotype enteritidis; Sigma-Aldrich Chemical Co., USA,
dissolved in sterile pyrogen-free saline, 0.05mg/kg) or an equiv-
olume of saline (Livingstone International, Australia). No signif-
icant differences in neonatal weight were observed when assessed
on PND 3, PND 5, and PND 7 in the female offspring. We have
previously reported neonatal LPS treatment to produce variable
effects in regards to the neonatal weight gain, inducing weight loss
(Walker et al., 2004; Sominsky et al., 2012a), weight gain (Walker
et al., 2011) or no significant change (Walker et al., 2009a). Litter
size and male-to-female ratio were not significant covariates to
this analysis, confirming that these factors did not contribute to
the possible developmental effects of litter.
On PND 7, female pups were euthanized by rapid decap-
itation. Ovaries were collected, frozen on dry ice and stored
at −80◦C until further analysis. For microarray and qRT-PCR
analyses, ovaries were obtained from 5 animals per treatment
group (derived from 2 LPS and 2 saline-treated litters). For west-
ern blotting analysis, ovaries were obtained from 4 animals per
treatment group (derived from 2 LPS and 1 saline-treated lit-
ters). An additional subset of ovarian samples was used for
the exploratory immunohistochemical analysis. Ovaries were
obtained from 3 LPS and 3 saline-treated animals (derived from
2 LPS and 2 saline-treated litters) on PND14. This later time point
was chosen to ensure a complete structural representation of the
neonatal ovary, as at this age the ovary has been shown to contain
antral follicles, which are completely absent prior to 12 days of age
(Carson and Smith, 1986).
RNA EXTRACTION
RNA was isolated from ovaries using RNeasy Mini Kit (Qiagen
Inc., Valencia, CA, USA) in accordance with the manufac-
turer’s instructions, with slight modifications. Briefly, ovaries
were homogenized in lysis buffer (RNeasy buffer RLT) using
a basic plastic homogenizer. The homogenized RNA was then
passed five times through a 20 gauge needle. Lysate was cen-
trifuged at 13,000 rpm for 3min at 25◦C. The supernatant was
collected, 350μl 70% ETOH added and mixed. The solution was
then transferred to an RNeasy spin column and placed in a 2ml
collection tube. Following 20 s centrifugation at 10,000 rpm the
flow through was discarded. Seven hundred micro liters of wash
buffer (RNeasy buffer RW1) was added to the RNeasy spin col-
umn, centrifuged for 20 s at 10,000 rpm, following which the
flow through was discarded. This step was repeated twice with
500μl of RNeasy buffer RPE. RNeasy spin column was placed
in a new 1.5ml collection tube, add 30μl RNase-free H2O were
added directly to the column membrane and centrifuged for
1min at 10,000 rpm to collect RNA. RNA concentrations were
determined using spectrophotometer, NanoDrop 2000c (Thermo
Fisher Scientific, Wilmington, DE USA) (refer to Table S1 for
RNA quality information). The extracted RNA was used for
microarray analysis and for verification by qRT-PCR.
MICROARRAY ANALYSIS
Total RNA obtained from neonatal ovaries (1–2μg) was sub-
mitted to the Australian Genome Research Facility (AGRF).
Microarray analysis was performed using Agilent SurePrint G3
Rat GE 8x60K Array platform. Total RNA obtained from neona-
tal ovaries was quality ascertained on the Agilent Bioanalyser
2100 using the NanoChip protocol (Table S1). A total of 1μg
was labeled using the Ambion Total Prep RNA amplification
kit (Applied Biosystems—AMIL1791). The quantity of amplified
product was ascertained using the Agilent Bioanalyser 2100 using
the NanoChip protocol. For the Agilent 8x60k chip format, 600 ng
of amplified cRNA was used for the Cy3 coupling process using a
ULS labeling kit (Kreatech EA-006). After coupling the dye, the
reaction was cleaned using the KREApure columns in the kit.
The Cy3 labeled cRNA samples were then fragmented using the
Ambion fragmentation kit (Applied Biosystems—AM8740). The
fragmented cRNA was quality checked on the Agilent Bioanalyser
2100 using the NanoChip protocol. The fragmented Cy3 labeled
cRNA was then prepared for hybridization to the Agilent 8x60k
Rat array using the GX hybridization kit (Agilent—5188-5242)
where each hybridization reaction had a final volume of 50μl.
The Agilent hybridization chambers were prepared according
to manufacturer’s instructions. Each sample was loaded onto
the Agilent hybridization gaskets slide which is placed into a
hybridization chamber. The 8x60k Rat array was carefully low-
ered onto the gasket to create a sealed array for each sample. The
hybridization chambers were then placed in a rotating hybridiza-
tion oven at 65◦C for 17 h. After hybridization, the chip was
washed using the appropriate protocols as outlined in the Agilent
manual using the GX washing buffers (Agilent—5188-5327).
Upon completion of the washing, the chips were then scanned
in the Agilent DNA Microarray Scanner (High Resolution). The
scanner operating software, Agilent Scan Control, converts the
signal on the array into a TIFF file which can be used for
subsequent analysis. The experiment was conducted in three bio-
logical replicates, which consisted of ovarian tissue obtained from
five animals per treatment group. Differentially expressed genes
were determined by a twofold difference and a significance level
of p < 0.05. Ingenuity Pathways Analysis (Ingenuity Systems,
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Redwood City, CA) software was used for further analysis to iden-
tify canonical signaling pathways affected by LPS treatment. The
data discussed in this publication have been deposited in NCBI’s
Gene Expression Omnibus and are accessible through GEO Series
accession number GSE46436 (http://www.ncbi.nlm.nih.gov/geo/
query/acc.cgi?acc=GSE46436).
REVERSE TRANSCRIPTION AND QUANTITATIVE REAL-TIME PCR
Reverse transcription was performed with 1μg of total RNAusing
a SuperScript® VILO™ cDNA Synthesis Kit (Invitrogen Corp.,
Carlsbad, CA, USA), according to manufacturers’ instructions,
by combining the components [5× VILO reaction mix (4μL),
10× SuperScript enzyme mix (2μL), RNA sample (up to 1μg),
diethyl pyrocarbonate (DEPEC) treated water (to 20μl)]. Tube
contents were gently mixed, incubated at 25◦C for 10min, and
then incubated at 42◦C for 60min. The reaction was terminated
at 85◦C at 5min. qRT-PCR was performed using SYBR Green
PCR Master Mix (Invitrogen, Carlsbad, CA, USA) on a 7500
RT-PCR Fast instrument (Applied Biosystems, Foster City, CA,
USA). Primer sequences were designed using the Primer3 soft-
ware (http://frodo.wi.mit.edu). Sequence specificity was tested
using the Basic Local Alignment Search Tool at NCBI (Altschul
et al., 1997) and primer pairs were obtained from Invitrogen
(custom DNA oligonucleotide synthesis service). PCR efficiency
for each pair of primers was determined by a standard curve
method, where C(t) values for serial dilutions are related to the
logarithm of the dilution factor, and the slope is a measure
for reaction efficiency. Information regarding primer sequences,
including product size and PCR efficiency, is listed in Table S2.
The 25μl PCR mixture consisted of 12.5μl SYBR Green PCR
Master Mix, 9.5μl water and 2μl of each primer was added to
1μl of the cDNA template (10 ng/ml). All reactions were per-
formed in duplicate under the following conditions: 95◦C for 20 s
and 40 cycles of 95◦C for 3 s and 60◦C for 30 s. Melting curve was
determined under the following conditions: 95◦C for 15 s, 60◦C
for 1min, 95◦C for 15 s and 60◦C for 15 s. The data were nor-
malized to an endogenous control, β-actin. A relative quantitative
measure of the target gene expression compared with β-actin
mRNA was analysed using the equation 2−C(t), where C(t) is
the threshold cycle at which fluorescence is first detected as sta-
tistically significant above background, and presented as a fold
increase relative to the saline control.
PROTEIN EXTRACTION AND WESTERN BLOTTING
Protein was extracted using RIPA buffer (150mM NaCl, 0.5%
sodium deoxycholate, 0.1% SDS, 50mM Tris, pH 8, 1%
Triton X-100), supplemented with a protease inhibitor cocktail
(ProteCEASE, G-Biosciences St. Louis, MO, USA). Protein con-
centration was determined using a Pierce BCA Protein Assay Kit
(Thermo Scientific, Rockford, IL, USA). Quantified aliquots were
separated by electrophoresis and transferred onto a nitrocellu-
lose Hybond C-Extra membrane (Amersham) prior to blocking
for 1 h in 5% skim milk powder in TBST (0.1% Tween-20), as
previously described (Sobinoff et al., 2010). After blocking, the
membranes were incubated overnight at 4◦C with goat poly-
clonal TLR4 (L-14) (diluted 1:200; Santa Cruz, sc-16240); goat
polyclonal PKCβ1 (C-16) (diluted 1:500; Santa Cruz, sc-209); or
rabbit polyclonal anti-JNK1 (diluted 1:2000; Abcam, ab10664)
primary antibodies. Following washing and incubation with
horseradish peroxidase-conjugated donkey anti-goat secondary
antibody (Santa Cruz, sc-2020) at a 1:3000 dilution or goat anti-
rabbit secondary antibody (Millipore DC03L) at a 1:2000 dilution
for 1 h at room temperature, proteins were visualized using an
ECL Detection Kit (GE Healthcare Life Sciences) according to
manufacturer’s instructions. The membranes were then stripped
of primary and secondary antibodies in Western Re-Probe
(G-Biosciences) according to the manufacturer’s instructions at
room temperature for 1 h and reprobed using a mouse mono-
clonal anti-α-tubulin (Sigma, T5168) as a loading control. The
densities of TLR4, PKCβ1 and JNK1 bands were visualized using
ImageQuant LAS 4000 imager (GE Healthcare Life Sciences).
The protein bands were measured using MultiGauge V3.0 (Fuji,
Stamford, CT, USA) software and were expressed as the ratio to
α-tubulin.
IMMUNOHISTOCHEMISTRY
Immunohistochemistry was used to localize TLR4, PKCβ1, and
JNK1 proteins in the neonatal ovaries and for proliferating cell
nuclear antigen (PCNA) detection of primordial follicle activa-
tion and growth. Ovaries were obtained from LPS and saline-
treated animals on PND14. Tissue was fixed in Bouin’s fixative
solution for 4 h, washed four times in 70% ethanol dehydrated,
embedded in paraffin and sectioned at 4μm. Slides were dewaxed
in xylene and rehydrated with subsequent washes in ethanol.
Antigen retrieval was carried out by microwaving sections for
3 × 3min in Na Citrate buffer (10mM Sodium Citrate, pH 6)
for TLR4, PKCβ1, and PCNA, and in Tris buffer (50mM, pH
10.6) for JNK1. Slides were allowed to cool before being blocked
in 3% BSA/Tris-buffered saline (TBS) for 1 h at room tempera-
ture. Sections were incubated overnight at 4◦C with anti-TLR4
(diluted 1:100; Santa Cruz, sc-16240); anti-PKCβ1 (1:200, Santa
Cruz, sc-209) and mouse monoclonal anti-PCNA (diluted 1:200;
Merck KGaA, NA03T). For detection of anti-JNK1 (diluted 1:500,
Abcam, ab10664) sections were incubated for 2 h at room tem-
perature. The above primary antibodies were used for Western
blotting prior to their application for the immunohistochem-
ical analysis, ascertaining antibodies specificity (Kurien et al.,
2011). Slides were then washed in TBS containing 0.1% Triton X-
100, and incubated with the appropriate fluorescent-conjugated
secondary antibodies (Alexa Fluor 594 donkey anti-goat IgG;
Alexa Fluor 594 goat anti-rabbit IgG and Alexa Fluor 594 goat
anti-mouse IgG; Invitrogen; 1:200 dilution). Sections were then
counterstained with 4#-6-diamidino-2-phenylindole (DAPI) for
2min, mounted in Mowiol (4-88, Sigma), viewed using an Axio
Imager A1 fluorescent microscope (Carl Zeiss MicroImaging,
Inc., Thornwood, NY) under fluorescent optics and pictures
taken using an Olympus DP70 microscope camera (Olympus
America, Center Valley, PA).
TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE dUTP NICK END
LABELING (TUNEL) ANALYSIS
Bouin’s fixed sections were dewaxed and rehydrated as mentioned
above. Slides were then boiled in Tris buffer (50mM, pH 10.6)
for 20min and treated with 20μg/ml Proteinase K for 15min in
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a humidified chamber. TUNEL analysis was then performed as
previously described (Sobinoff et al., 2010, 2011, 2012) using an
In Situ Cell Death Detection Kit, Fluorescein (Roche Diagnostics
Pty Ltd), according to themanufacturer’s instructions. Slides were
then counterstained with DAPI for 5min, mounted in Mowiol,
and viewed using an Axio Imager A1 fluorescent microscope
(Carl Zeiss) under fluorescent optics and pictures taken using an
Olympus DP70 microscope camera (Olympus).
DATA ANALYSIS
Statistical analyses were conducted using the Statistical Package
for the Social Sciences for Windows, Version 18 (SPSS Inc.). Data
were analysed using analyses of variances (ANOVA) design. The
significance level was set at p ≤ 0.05.
RESULTS
IMPACT OF LPS TREATMENT ON THE NEONATAL OVARIAN
TRANSCRIPTOME
Administration of LPS on PNDs 3 and 5 caused a significant
change in ovarian gene expression for 712 genes, representing
2.4% of the total number of genes present on the array, with sig-
nificant upregulation of 710 genes (Figure 1; Table S3). Further
functional analysis using Ingenuity Pathway Analysis software
identified these significantly altered genes as components of sev-
eral molecular networks implicated in cell signaling, immune cell
trafficking, inflammatory response as well as reproductive devel-
opment and disease (see Table 1). These results suggest a robust
impact of peripheral immune challenge on a variety of molec-
ular mechanisms regulating ovarian development and function.
No distinct function has been assigned to the two significantly
downregulated genes, SBK2 and TEDDM1.
CANONICAL PATHWAYS SIGNIFICANTLY UPREGULATED BY NEONATAL
LPS EXPOSURE
Further functional assessment of differentially regulated genes
revealed several canonical pathways involved primarily in
immune recognition and inflammation were activated in
response to neonatal treatment [e.g., virus entry via endocytic
pathways; nuclear factor-kappaB (NF-κB) activation; mitogen-
activated protein kinase (MAPK) signaling; pattern-recognition
receptors signaling; MSP-RON signaling, whereby macrophage-
stimulating protein (MSP), acts through the RON receptor tyro-
sine kinase, and plays a regulatory role in the inflammatory
response], suggesting dysregulation of inflammatory processes in
response to peripheral LPS exposure may occur also locally, in
the ovary (Figure 2; Table S4). Figures A1–A7 provide a graph-
ical representation of the significantly altered genes in the top
canonical pathways.
qRT-PCR CONFIRMATION OF MICROARRAY ANALYSIS
LPS-stimulated MAPK signaling pathway was chosen for vali-
dation of microarray results, due to its specific relevance to the
current model of LPS challenge. qRT-PCR analysis confirmed sig-
nificant upregulation of 8 out of 9 genes that were identified as
Table 1 | Functional categorization of genes that were upregulated by
neonatal LPS exposure.
Molecular and cellular function Upregulated genes
Inflammatory response 50
Immune cell trafficking 29
Inflammatory disease 54
Organismal development 38
Developmental disorder 39
Reproductive system development and function 29
Reproductive system disease 28
DNA replication, recombination, and repair 34
Cell morphology 32
Significantly upregulated genes were analysed using Ingenuity Pathway Analysis
software for molecular and cellular functions. Only those genes exhibiting a
greater than two-fold change in expression were analysed (p < 0.05). Some
genes are listed in multiple functional groups.
FIGURE 1 | Microarray analysis of neonatal ovaries obtained from
LPS-treated vs. saline-treated animals, on PND 7. RNA was isolated and
subjected to microarray analysis as described in the Methods section. Total
number of genes present on an Agilent SurePrint G3 Rat GE 8x60K Array are
presented as non-regulated (black) and regulated (white) genes with a
significant change in expression (≥2-fold change, p < 0.05). The red bar
represents the number of upregulated genes and the green bar represents
the number of downregulated genes in the ovaries of LPS-treated animals.
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FIGURE 2 | Top canonical pathways that were significantly upregulated
by neonatal LPS treatment, as identified by Ingenuity Pathway Analysis.
The significance of association between upregulated genes and the canonical
pathway was assessed using a right-tailed Fisher’s exact test to calculate a
p-value determining the probability that the association is explained by
chance alone (blue bars, y-axis). Ratios defining the proportion of upregulating
genes from a pathway related to the total number of molecules that make up
that particular pathway are also displayed (line graph, z-axis).
components of this pathway, in the ovaries of LPS-treated animals
(Table 2). Of these genes, upregulation ofMAPK8/JNK1 has been
previously associated with oocyte dysfunction (Sobinoff et al.,
2010); PKCβ has been reported to be involved in oocyte activa-
tion (Carbone and Tatone, 2009); PIK3C2A has been implicated
in proliferation of ovarian theca-interstitial cells (Kwintkiewicz
et al., 2006); PIK3R1 and PKCZ have been associated with the
incidence of PCOS (Diamanti-Kandarakis, 2008; Kim et al., 2009;
Rivero et al., 2012); PKD3 has been implicated in organogenesis
(Ellwanger et al., 2008); RELA and RRAS2 have been associ-
ated with ovarian tumorigenesis (Chan et al., 1994; Niesporek
et al., 2007; Fan and Richards, 2010); and finally, increased
expression of TLR4 (receptor for LPS) has been demonstrated to
underpin impaired follicular growth and function (Herath et al.,
2007).
PROTEIN ANALYSIS BY WESTERN BLOTTING
To further validate the microarray results, immunoblotting anal-
ysis was performed to examine protein expression of three sig-
nificantly upregulated genes (TLR4; PKCβ; MAPK8/JNK1) in the
LPS-stimulated MAPK signaling pathway. Densitometry anal-
ysis of protein expression in the ovaries of LPS-treated rats,
as compared to α-tubulin, revealed a significant increase of
two protein bands associated with TLR4 expression [F(1, 5) =
10.2; F(1, 5) = 17.06, p < 0.05 for both]. No significant differ-
ences were evident in the expression of PKCβ1, however, a
trend was observed in increased expression of JNK1 protein
in the ovaries of LPS-treated animals [F(1, 5) = 4.12, p = 0.09;
see Figure 3B]. Representative immunoblots are presented in
Figure 3A.
IMMUNOHISTOCHEMICAL ANALYSIS
To detect localization of TLR4, PKCβ1 JNK1, in the neona-
tal ovary, observational immunohistochemical staining was per-
formed in the ovaries of LPS and saline-treated animals, obtained
on PND14. As demonstrated in Figures 4A,B, TLR4 immunola-
beling was detected in the oocytes. In the ovaries of LPS-treated
animals TLR4 was also detected in ovarian blood vessels, suggest-
ing activation of local immune cells. PKCβ1 staining was evident
in the ovarian blood vessels, to a greater extent in the ovaries
of LPS-treated animals (Figures 4C,D). JNK1 immunolabeling
was detected in theca cells, in both treated and control samples
(Figures 4E,F).
LPS and saline-treated ovaries were also probed for mark-
ers of follicular activation and cell death. PCNA staining was
equally detected in the granulosa cells and the oocytes of pri-
mordial, primary and secondary follicles in both treatment and
saline control group. TUNEL staining did not reveal any signif-
icant apoptosis in either of the experimental groups (data not
shown).
DISCUSSION
In this study we assessed, for the first time, the effect of immune
challenge by peripheral administration of LPS on the ovarian
transcriptome in neonatal rats. Microarray analysis revealed spe-
cific activation of immune-related pathways, such as virus entry
via endocytosis, NF-κB activation by viruses, role of pattern
recognition receptors in recognition of bacteria and viruses, LPS-
stimulated MAPK pathway and MSP-RON signaling pathway.
Exposure to LPS upregulated expression of genes implicated in
cell signaling, immune cell trafficking, inflammatory response as
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Table 2 | qRT-PCR confirmation of microarray results for the components of LPS-stimulated MAPK signaling pathway, upregulated in the
ovaries of LPS-treated animals.
Gene symbol Gene name Summary of function Fold change
MAPK8/JNK1 Mitogen-activated protein kinase/c-Jun
N-Terminal Protein Kinase 1
Increased expression is associated with xenobiotic-induced
oocyte dysfunction (Sobinoff et al., 2010)
2.99 ± 0.04*
PIK3C2A Phosphatidylinositol-4-phosphate 3-kinase,
catalytic subunit 2A
Involved in modulation of proliferation of ovarian mesenchyme
(Kwintkiewicz et al., 2006)
2.74 ± 0.04*
PIK3R1 Phosphoinositide-3-kinase, regulatory subunit 1 Involved in the insulin receptor signaling pathway; associated in
the pathogenesis of PCOS (Kim et al., 2009)
3.32 + 0.04*
PKCβ Protein kinase C, beta Involved in oocyte activation. Reduced expression of PKCβ1 is
associated with ageing (Carbone and Tatone, 2009)
3.71 ± 0.04*
PKCZ Protein Kinase C, Zeta Involved in the insulin pathway; decreased expression in PCOS
patients (Diamanti-Kandarakis, 2008; Rivero et al., 2012)
−1.61 ± 0.06
PKD3 Protein kinase, D3 Implicated in organogenesis (Ellwanger et al., 2008) 5.11 ± 0.04*
RELA v-rel reticuloendotheliosis viral oncogene
homolog A
Downregulated in women with preeclampsia (Hansson et al.,
2006). Upregulated in ovarian carcinoma, leading to
overexpression of COX-2 (Niesporek et al., 2007)
3.72 ± 0.04*
RRAS2 Related RAS viral oncogene homolog 2 Oncogene, defects in RRAS2 increase susceptibility to ovarian
cancer (Chan et al., 1994; Fan and Richards, 2010)
7.45 ± 0.07*
TLR4 Toll-like receptor 4 Expressed by granulosa cells, mediating the effect of bacterial
infection on impaired ovarian follicle growth and function (Herath
et al., 2007)
2.35 ± 0.1*
Fold changes are reported as mean ± SEM. *p < 0.05.
FIGURE 3 | Protein expression of TLR4, PKCβ, and JNK1 in the neonatal
ovary. (A) Changes in protein expression, as identified by immunoblotting
analysis, are presented as a fold change relative to the saline control. (B)
Representative immunoblots demonstrate the effect of LPS and saline
treatments. Filled bars represent LPS-treated rats, hollow bars represent
saline controls. Values are mean ± SEM. ∗p < 0.05.
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FIGURE 4 | Fluorescent immunolocalization of TLR4, PKCβ, and JNK1
protein in the ovaries of LPS and saline-treated animals. (A–B) Represent
TLR4 immunolabeling detected in the oocytes; (C–D) Represent PKCβ1
immunolabeling in ovarian blood vessels; (E–F) Represent JNK1
immunolabeling in theca cells. Insert at higher magnification is located at the
bottom left corner of each representative micrograph. Blue staining (DAPI)
represents nuclear staining; red staining represents specific staining for the
protein of interest.
well as reproductive development and disease, suggesting dysreg-
ulation of inflammatory processes in response to peripheral LPS
exposure may occur also locally in the ovary, contributing directly
to programming of reproductive health.
Given the specific relevance of LPS-stimulated MAPK path-
way to the model of neonatal LPS exposure, microarray results
were confirmed and elaborated on the altered components of this
pathway. Activation of MAPK signaling by LPS binding of TLR4
results in transcriptional regulation and synthesis of inflamma-
tory agents, such as tumor necrosis factor-α (TNF-α), interleukin
1β (IL-1β) and IL-6, as well as nitric oxide synthase-2 (NOS2) and
cyclooxygenase-2 (COX2) (Nagano et al., 2002; Kawai and Akira,
2007). Other downstream targets include phosphoinositide-3-
kinase (PI3K), which stimulation enhances activity of protein
kinase C (PKC) (Frey et al., 2006). In the current study, several
subunits of these genes, identified with the MAPK pathway, were
upregulated in the ovaries of LPS-treated animals.
PI3K has been reported to induce activation of the ser-
ine/threonine kinase Akt, also known as protein kinase B (PKB),
which in turn stimulates the mammalian target of rapamycin
(mTOR) protein. Overactivation of PI3K/Akt/mTOR signaling
pathway, induced by exposure to carcinogens and xenobiotics, has
been implicated in premature activation of primordial follicles,
leading to early follicular atresia (McLaughlin and Sobinoff, 2010;
Sobinoff et al., 2010, 2011). Activation of PI3K/Akt has also been
associated with the development of PCOS (Lima et al., 2006).
While in the current study immunohistological assessment for
markers of follicular activation and atresia revealed no significant
alterations were induced by neonatal LPS exposure, our previ-
ous findings have indicated diminished population of primordial
follicles in the late neonatal period in the ovaries of LPS-treated
females (Sominsky et al., 2012a). These data suggest that apop-
totic processes may occur early on, during the acute response to
the LPS immune challenge, hindering follicular development.
The current model of neonatal LPS administration induces an
acute pro-inflammatory response which involves the release of
pro-inflammatory cytokines (i.e., TNF-α, IL-6, IL-1β), and this
response typically resolves within 3–6h from the time of drug
administration, followed then by an anti-inflammatory release of
glucocorticoids (Walker et al., 2004, 2009b). This brief activation
of the immune response has been recently shown to impact on the
development of the immune, reproductive, endocrine, metabolic,
nervous and other physiological systems (Walker et al., 2010; Wu
et al., 2011; Amath et al., 2012; Sominsky et al., 2012a, 2013).
In the rat, the primordial follicle pool undergoes its final stages
of formation and assembly postnatally, continuing till approxi-
mately day 3 after birth (Rajah et al., 1992; Skinner, 2005). This
process is considered to be gonadotropin independent, supported
and guided by growth factors and cytokines, one of which is the
proinflammatory cytokine TNF-α. Previous research has demon-
strated that ovarian TNF-α in the neonatal rat has an important
role in determining the finite size of the primordial follicle pool.
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It has been demonstrated in vitro that TNF-α can decrease the
number of oocytes and primordial follicles, via induction of
apoptosis (Morrison and Marcinkiewicz, 2002). The formation
of primordial follicles is then followed by the initial event of
follicular development—transition to the primary follicle stage
(Fortune et al., 2000; Skinner, 2005). As opposed to the later
stages of follicular development, the transition from primordial to
primary stage is hormone independent (Skinner, 2005). Exposure
to LPS in adulthood has been also shown to induce follicu-
lar atresia in vivo in mice (Bromfield and Sheldon, 2013) and
rats (Besnard et al., 2001) and in vitro in cattle (Bromfield and
Sheldon, 2013). Interestingly, LPS-induced atresia is particularly
detrimental to the population of primordial follicles (Bromfield
and Sheldon, 2013), indicating that depletion of the primor-
dial follicle pool during early development would subsequently
impact the ovarian reserve and result in impaired fertility in
later life. To our knowledge, no studies have assessed the gene
expression of ovarian inflammatory pathways which were exam-
ined in the current study. While it is likely that similar changes
would be evident in response to adult LPS exposure, the impact
of such changes during early development, when the ovary has
not yet morphologically and functionally developed, has signifi-
cantly stronger implications for the growing follicle populations.
It is therefore plausible to suggest that the neonatal LPS treat-
ment instantly interferes with the delicate process of primordial
follicle pool assembly and the subsequent activation of follicular
development, through stimulation of an acute pro-inflammatory
response. While this might be a transient perturbation, it ulti-
mately leads to long lasting alterations in the size of the follicular
pool, as observed in previous studies (Wu et al., 2011; Sominsky
et al., 2012a). Even though no evidence of primordial follicle acti-
vation or apoptosis was evidenced in the current study, these
processes might have occurred at an earlier time-point. Therefore,
further investigation is required to clarify the time-course of
apoptotic processes leading to the diminished follicular reserve
reported in later life following neonatal exposure to LPS.
Activation and growth of primordial follicles are stimulated
by several signaling pathways, including the MAPK and PKC (Jin
et al., 2005; Du et al., 2012). The expression of several PKC iso-
forms (PKC α, β, δ, and ζ) was previously identified in the rat
ovary (Cutler et al., 1994). In the neonatal rat ovary, MAPK, and
PKC signaling cascade is involved in maturation of primordial
follicles (Du et al., 2012). In the current study increased gene
expression of MAPK8 and PKCβ in the ovaries of LPS-treated
animals was determined by the microarray analysis and further
confirmed by qRT-PCR. No significant changes in the expression
of MAPK8 and PKCβ1 proteins were evident at the same time-
point. However, significant increase in protein expression of TLR4
was found in the LPS-treated ovaries, and was associated with the
increased mRNA levels of this gene.
TLR4, pathogen-associated molecular pattern recognition
receptor, is expressed by innate immune and tissue specific cells,
and recognizes bacterial molecules (e.g., LPS) (Medzhitov, 2001).
While TLR4 activation is critical for generation of both innate and
adaptive immune responses, its inappropriate activation can be
harmful (Peroval et al., 2013). TLR4s are present in the ovary and
expressed by ovarian surface epithelial cells, granulosa/cumulus
cells (Herath et al., 2007; Liu et al., 2008; Richards et al., 2008),
as well as by ovarian macrophages (Zhou et al., 2009), and play
an essential role in regulation of fertility, through the support
of ovulation and sperm capacitation (Liu et al., 2008; Shimada
et al., 2008). Ovarian TLR4 signaling is normally induced by
endogenous ligands, one of such is hyaluronan (HA)-rich matrix
(Richards et al., 2008). Its synthesis during the ovulatory process
is initiated by the surge of luteinising hormone (LH). HA-rich
matrix is then recognized by cumulus cells, inducing inflamma-
tion and expression of innate immune-related genes, leading to
the release of prostaglandins, TNF-α, IL-6 and other cytokines,
and chemokines (Liu et al., 2008; Richards et al., 2008). These
inflammatory agents activate chemokine receptors present on
sperm, inducing sperm capacitation and motility (Shimada et al.,
2008). Even though regulated production of cytokines is essen-
tial for ovulation and successful fertilization, dysregulation of
cytokine production can impair fertility (Richards et al., 2008). In
human patients, the existence of endometriosis was found to be
associated with increased levels of IL-6 in circulation and in the
follicular fluid, and is proposed to be related to the impaired fol-
licular development and decreased oestradiol production, which
results in infertility (Garrido et al., 2000; Pellicer et al., 2000).
Activation of ovarian TLR4 by LPS has been studied in various
animal and in vitro models. For instance, impaired antral follicle
growth and function, as well as suppressed oestradiol production
were reported in response to uterine E. coli infection, intravenous
infusion with LPS and following exposure of granulosa cells to
LPS in vitro, in cattle and sheep (Battaglia et al., 2000; Herath
et al., 2007; Sheldon et al., 2009). A recent study in adult mice
has demonstrated that LPS-induced atresia of primordial folli-
cles is mediated via TLR4, since no follicle atresia was evident in
TLR4-deficient mice (Bromfield and Sheldon, 2013).
The long-term effect of neonatal LPS exposure on TLR4
expression has been previously assessed in adult rats. Increased
TLR4 mRNA expression was evident in the spleen and liver,
two primary organs responsible for the synthesis of pro-
inflammatory cytokines (Tracey, 2002), of neonatally-treated ani-
mals (Mouihate et al., 2010). In addition, increased expression
of COX-2, the principal target of TLR4 activation, in the liver of
LPS-treated animals was associated with a transient rise in cir-
culating prostaglandin and increased activation of the HPA axis,
in response to adult LPS exposure (Mouihate et al., 2010). These
outcomes suggest that early life exposure to LPS has a persistent
programming effect on the neuroimmune axis and this occurs via
activation of TLR4. The current findings report that postnatal
LPS challenge results in increased mRNA and protein expres-
sion of TLR4 in the neonatal ovary. In addition to its role in
the LPS-stimulated MAPK pathway, TLR4 was associated with
a number of inflammatory pathways activated in response to
the neonatal treatment, as revealed by the canonical pathways
analysis (i.e., role of pattern recognition receptors, MSP-RON
and NF-κB signaling pathways). Given the important regulatory
role of TLR4 in reproductive function, activation of the recep-
tor and the subsequent pro-inflammatory cascade in early life
are most likely to have significant effects on ovarian develop-
ment. Imbalance in the internal ovarian milieu may potentially
interrupt the delicate process of follicular formation and growth,
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compromising reproductive capacity. Importantly, the process
of primordial follicle assembly and development is highly con-
served between mammals, and similar regulation of this process
is considered to occur in different species, including humans
(Skinner, 2005). Thus, while further studies are required to
elucidate the immune mechanisms involved in the impaired
ovarian development and functioning, our results importantly
suggest that exposure to an immune challenge in early life,
resulting in activation of TLR-related inflammatory pathways,
may have significant consequences for programming of repro-
ductive health in later life. Moreover, given that alterations
in TLR4 expression are associated with pathological outcomes
of common bacterial infections, such as Escherichia coli and
Chlamydia trachomatis, including impaired fertility (Herath et al.,
2009; Laisk et al., 2010), the current findings provide a valu-
able insight into the link between early life infection and
fertility.
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found online
at: http://www.frontiersin.org/Neuroendocrine_Science/10.3389/
fnins.2013.00100/abstract
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APPENDIX
A graphical representation of the top canonical pathways that
were significantly upregulated by neonatal LPS treatment, as
identified by Ingenuity Pathway Analysis. Red shading indicates
up-regulation of the gene. No color indicates genes that form the
pathway and have no change.
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FIGURE A2 | NF-κB activation by viruses.
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FIGURE A4 | LPS-stimulated MAPK signaling.
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FIGURE A6 | MSP-RON signaling pathway.
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FIGURE A7 | Endothelin-1 signaling.
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